CD4 and neoplasm: However, the immunogenicity may be low enough to provide protection against tumor cells, therefore antigen delivery and role of adjuvants is important to enhance immunogenicity of this protein Furthermore, both CD4 and CD8 restricted epitopes from Survivin protein are important for induction of effective anti-tumour immune response.